TuHURA Biosciences (HURA) Retained Earnings (2011 - 2026)
TuHURA Biosciences' (HURA) quarterly Retained Earnings came in at -$148.7 million in Q1 2026, down 26.26% year-on-year from -$201.7 million in Q1 2025, and down 5.34% quarter-over-quarter from -$141.2 million in Q4 2025.
TuHURA Biosciences (HURA) Retained Earnings (2011 - 2026) Analysis & Trends
TuHURA Biosciences' Retained Earnings history runs 16 years deep, the most recent figure standing at -$148.7 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 26.26% year-over-year to -$148.7 million in Q1 2026; TTM through Mar 2026 was -$148.7 million, a 26.26% decrease from a year earlier, with the FY2025 full-year figure at -$141.2 million, down 27.05% from the prior year.
- Retained Earnings eased to -$148.7 million in Q1 2026 per HURA's latest filing, from -$141.2 million in the prior quarter.
- Across five years, Retained Earnings topped out at $21000.0 in Q3 2022 and bottomed at -$162.1 million in Q3 2024.
- The 5-year median for Retained Earnings is -$127.3 million (2025), against an average of -$94.7 million.
- Across the five-year window, Retained Earnings surged 100.02% in 2023 and plunged 750338.1% in 2024, its largest moves.
- Year by year, Retained Earnings stood at $21000.0 in 2022, then sank by 421409.51% to -$88.5 million in 2023, then dropped by 25.6% to -$111.1 million in 2024, then decreased by 27.05% to -$141.2 million in 2025, then decreased by 5.34% to -$148.7 million in 2026.
- Per Business Quant, the three latest HURA Retained Earnings figures stand at -$148.7 million (Q1 2026), -$141.2 million (Q4 2025), and -$134.4 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | -148.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -148.72 Mn |
| Dec 31, 2025 | -141.18 Mn |
| Sep 30, 2025 | -134.42 Mn |
| Jun 30, 2025 | -127.32 Mn |
| Mar 31, 2025 | -117.79 Mn |
| Dec 31, 2024 | -111.12 Mn |
| Sep 30, 2024 | -162.05 Mn |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | -157.55 Mn |
| Dec 31, 2023 | -88.47 Mn |
| Sep 30, 2023 | -154.51 Mn |
| Jun 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 21,000.00 |
| Jun 30, 2022 | -136.36 Mn |
| Mar 31, 2022 | -130.91 Mn |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 21,000.00 |
| Jun 30, 2021 | -111.23 Mn |